Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Karyopharm Therapeutics (KPTI) Interest Coverage Ratio (2019 - 2025)

Karyopharm Therapeutics' Interest Coverage Ratio history spans 9 years, with the latest figure at 2.51 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 189.99% year-over-year to 2.51; the TTM value through Dec 2025 reached 0.9, up 71.87%, while the annual FY2025 figure was 0.9, 71.87% up from the prior year.
  • Interest Coverage Ratio reached 2.51 in Q4 2025 per KPTI's latest filing, up from 1.38 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 5.91 in Q4 2021 to a low of 10.28 in Q1 2021.
  • Average Interest Coverage Ratio over 5 years is 4.11, with a median of 5.13 recorded in 2023.
  • Peak YoY movement for Interest Coverage Ratio: skyrocketed 212.85% in 2021, then crashed 197.3% in 2022.
  • A 5-year view of Interest Coverage Ratio shows it stood at 5.91 in 2021, then crashed by 197.3% to 5.76 in 2022, then decreased by 5.82% to 6.09 in 2023, then surged by 54.16% to 2.79 in 2024, then skyrocketed by 189.99% to 2.51 in 2025.
  • Per Business Quant, the three most recent readings for KPTI's Interest Coverage Ratio are 2.51 (Q4 2025), 1.38 (Q3 2025), and 2.17 (Q2 2025).